Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NUVB
#3994
Nuvation Bio Inc.
5.9
2
+5.71%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+5.71%
Monthly Change
+5.53%
6 month change
+98.66%
Year Change
+203.59%
Previous Close
5.6
0
Open
5.7
9
Bid
Ask
Low
5.7
9
High
5.9
2
Volume
1 640
Markets
US Stock Market
Healthcare
NUVB
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Tracking David Abrams' Abrams Capital Management Portfolio - Q4 2025 Update
Nuvation Bio expands SIGMA trial to phase 3 for IDH1-mutant glioma
Nuvation Bio stock maintains Buy rating at B.Riley on Ibtrozi sales momentum
Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy (NYSE:NUVB)
Truist Securities raises Nuvation Bio stock price target to $13 on Ibtrozi uptake
Jones Trading raises Nuvation Bio stock price target to $12 on safusidenib study
Down 24% in 4 Weeks, Here's Why Nuvation Bio (NUVB) Looks Ripe for a Turnaround
Nuvation Bio stock price target lowered to $17 at H.C. Wainwright
Nuvation Bio stock rating reiterated at Market Outperform by Citizens
Alibaba, American Express among market cap stock movers on Monday
Eisai to license taletrectinib for ROS1+ lung cancer across Europe, Asia